Moreover, in patients with NAFLD low adiponectin was independently associated with the severity of steatosis, as well as with NASH and fibrosis, in line with the hypothesized role of adiponectin in the progression of liver damage [9,11,13,35]. Here, ADIPOQ is linked to metabolic dysfunction-associated steatohepatitis.